Ryan Specialty (RYAN) Projected to Post Earnings on Thursday

Ryan Specialty (NYSE:RYAN) is projected to issue its quarterly earnings data after the market closes on Thursday, February 20th. Analysts expect the company to announce earnings of $0.47 per share and revenue of $658.80 million for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

Ryan Specialty Trading Up 1.2 %

Shares of NYSE RYAN opened at $69.55 on Wednesday. The firm’s 50 day moving average price is $65.56 and its 200-day moving average price is $67.23. The company has a market cap of $18.21 billion, a PE ratio of 90.33, a P/E/G ratio of 1.19 and a beta of 0.72. Ryan Specialty has a 52-week low of $45.55 and a 52-week high of $75.97. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01.

Insider Activity at Ryan Specialty

In other Ryan Specialty news, Director David P. Bolger sold 7,055 shares of the stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total value of $500,058.40. Following the transaction, the director now directly owns 78,149 shares in the company, valued at approximately $5,539,201.12. This trade represents a 8.28 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of $67.39, for a total transaction of $2,358,650.00. Following the completion of the transaction, the director now owns 65,100 shares in the company, valued at $4,387,089. The trade was a 34.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 323,506 shares of company stock worth $21,407,851 over the last quarter. Company insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

RYAN has been the topic of several analyst reports. Morgan Stanley initiated coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 target price on the stock. Barclays upped their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. Keefe, Bruyette & Woods dropped their target price on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a research note on Friday, January 10th. Finally, Wells Fargo & Company dropped their target price on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a research note on Tuesday, January 14th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, Ryan Specialty currently has a consensus rating of “Hold” and a consensus price target of $74.40.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.